Mr. William Hu is a Managing Partner of Qiming Venture Partners. William co-leads Qiming's investments in the healthcare sector.
William has been closely involved in the development of over 40 startup firms, some of which have become public companies or billion-dollar market cap companies.
William has led investments in Tigermed(SZSE: 300347, SEHK:3347), BBI Lifescience (HK: 01035), Tellgen(SZ: 300642), AmoyDx(SZ: 300685), APT Medical (SHSE:688617), Sanyou Medical (SHSE:688085) , Antengene(SEHK:6996), Connect Pharma(Nasdaq: CNTB), Vinno Medical, IntoCare Medtech, Aohua Medical, Microtech Medical, Rendu Bio, ET Healthcare, Canbridge, Ark Bio, WeDoctor, Miaoshou Doctor, Medsci, Arrail Dental, Bang'Er Orthopedics Hospitals, ShuLan Hospital, Centreherbs, Health Genetech, etc.
William earned a Bachelor of Medicine degree from Shanghai Medical University and an MBA degree from ENPC SH Campus.